BIOMAT Database Logo BIOMAT Database Logo

Serum pancreatic enzyme levels in cystic fibrosis heterozygotes after secretin and cholecystokinin infusion. 1982

E A Mitchell, and R B Elliott

UI MeSH Term Description Entries
D008297 Male Males
D010194 Pancreatin A mammalian pancreatic extract composed of enzymes with protease, amylase and lipase activities. It is used as a digestant in pancreatic malfunction. Panteric,Panzytrat
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000516 alpha-Amylases Enzymes that catalyze the endohydrolysis of 1,4-alpha-glycosidic linkages in STARCH; GLYCOGEN; and related POLYSACCHARIDES and OLIGOSACCHARIDES containing 3 or more 1,4-alpha-linked D-glucose units. Taka-Amylase A,alpha-Amylase,Alpha-Amylase Bayer,Maxilase,Mégamylase,alpha-1,4-D-Glucanglucanohydrolase,Alpha Amylase Bayer,AlphaAmylase Bayer,Taka Amylase A,TakaAmylase A,alpha 1,4 D Glucanglucanohydrolase,alpha Amylase,alpha Amylases
D012633 Secretin A peptide hormone of about 27 amino acids from the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. (USAN and the USP Dictionary of Drug Names, 1994, p597) Secrepan,Secretin Citrate, Pig,Secretin Maleate, Pig,Secretin Pentacetate, Pig,Secretin Sulfate, Pig,Secretin, Pig,Secretin-KABI,Pig Secretin,Pig Secretin Citrate,Pig Secretin Maleate,Pig Secretin Pentacetate,Pig Secretin Sulfate,Secretin KABI,SecretinKABI
D014362 Trypsinogen The inactive proenzyme of trypsin secreted by the pancreas, activated in the duodenum via cleavage by enteropeptidase. (Stedman, 25th ed) Trypsinogen 1

Related Publications

E A Mitchell, and R B Elliott
Serum lipase after secretin stimulation detects mild pancreatic involvement in cystic fibrosis.
April 2004, Journal of pediatric gastroenterology and nutrition,
E A Mitchell, and R B Elliott
Pancreatic enzyme response to secretin and cholecystokinin-pancreozymin in the rat.
October 1973, The Journal of physiology,
E A Mitchell, and R B Elliott
Cystic fibrosis mutations for p.F508del compound heterozygotes predict sweat chloride levels and pancreatic sufficiency.
December 2012, Clinical genetics,
E A Mitchell, and R B Elliott
Serum pancreatic isoamylases in the diagnosis of cystic fibrosis heterozygotes: A non-valuable test.
January 1977, Clinical genetics,
E A Mitchell, and R B Elliott
[Serum levels of pancreatic and salivary isoamylases in cystic fibrosis].
April 1982, Minerva pediatrica,
E A Mitchell, and R B Elliott
Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis.
November 1985, Gut,
E A Mitchell, and R B Elliott
[Central action of cholecystokinin-pancreozymin and secretin on pancreatic enzyme secretion].
September 1981, Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova,
E A Mitchell, and R B Elliott
Similar sensitivities of pancreatic and biliary secretion to cholecystokinin plus secretin infusion.
August 1976, The American journal of digestive diseases,
E A Mitchell, and R B Elliott
Pancreatic enzyme supplementation in cystic fibrosis.
January 1993, Archives of disease in childhood,
E A Mitchell, and R B Elliott
Pancreatic enzyme therapy in cystic fibrosis.
December 2008, Expert review of respiratory medicine,
Copied contents to your clipboard!